Thursday, March 18, 2021

Media alert for #CBD/ #FunctionalMushroom #Stock Link Reservations Inc/LinkResPet (OTC: $LRSV) @res_pet


Media alert for #CBD/ #FunctionalMushroom #Stock Link Reservations Inc/LinkResPet (OTC: $LRSV) @res_pet


Goldman Small Cap Research Issues New Research Report on Link Reservations, Inc.


London, UK –  March 18, 2021 - CBD/Functional mushroom stock media alert from NewswireLink Reservations Inc. (OTC: LRSV), a provider of cannabidiol (CBD) products and functional mushroom products was featured in a recent research report .


Read this news, featuring LRSV in full at


Goldman Small Cap Research

Full news


Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new research report on Link Reservations, Inc. (OTC PINK:LRSV). The Company is an emerging player in the fast-growing CBD and functional mushrooms markets. This report carries a price target. To view the new research report along with disclosures and disclaimers, or to download them in their entirety, please visit

Link Reservations Inc is a CBD Pet Care provider dedicated to improving the health and life conditions of pets worldwide. Developing and marketing hemp-based CBD products for cats, dogs and horses, the Company is currently present in Europe and in the US. Link also recently launched a sister site for humans, According to a recent report from Grandview Research, the global Pet CBD market is slated to jump from $27M in 2020 to $400M in 2027, a 40% Compound Annual Growth Rate (CAGR). Meanwhile, Grandview also projects the global CBD market will grow from an estimated $3.5B in 2021 to $13.4B in 2028, a 21% CAGR.

In the Opportunity Research report, analyst Rob Goldman discusses the potential of the Company's Pet CBD and functional mushroom lines and how success in these markets may result in a future premium valuation.

Goldman noted, "Through its two subsidiaries, LRSV is poised to generate a meaningful share in some of the fastest growing wellness markets, namely hemp-based CBD-infused products for pets and humans, and functional mushrooms. The Company offers diverse products in niche, high growth markets and is one of the few CBD products firms to offer products in the US and Europe."

"The projected 40% compound annual growth rate (CAGR) for the Pet CBD market over the next few years illustrates the strong appetite for the offerings. Plus, the unprecedented pet ownership during the pandemic, especially by millennials, fuels this opportunity. CBDs are used to treat anxiety, inflammation, pain, and other conditions. LRSV plans to introduce new mushroom-infused products to treat stress and sleep disorders," continued Goldman.

"The convergence of key markets such as pet care, CBDs, functional mushrooms and potentially psychedelic mushrooms could foster considerable growth, success, and valuation premiums for LRSV. Thus, our target price represents a premium to key CBD-infused product peers," concluded Goldman.


To learn more about LinkResPet or to purchase CBD pet products, please visit: or follow us on twitter at @res_pet.


Forward-Looking Statements & Disclaimers:
The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.


Linkreservations Inc

400 Thames Valley Park Drive

Reading Berkshire RG6 1 PT

United Kingdom

Phone: +44 330 808 0897


Paid News -Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring LRSV is a paid for news release on  More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Please read privacy policy:

About and

Sign up for free stock news alerts at

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others. 

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories


No comments:

Post a Comment